By the mid-1990s, the basic rules of engagement, determined by the FDA and the U.S. Patent and Trademark Office, had been settled to the lasting benefit of business: a strong patent system and no pricing restrictions led to a profound shift of pharmaceutical investment into the United States and away from Europe, where government price setting was increasingly common. By 2002 global drugmakers were spending 82 percent of their money in the United States. The U.S. pharmaceutical industry has grown twice as fast as the economy at large since 1990.
The reason drug prices are so high in the us is tha congress has sold a territory to the pirates, and made legal their plunder.
